NECTAR LIFESCIENCES
Back to Income Statement
|
NECTAR LIFESCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-114 Cr | ₹5.00 Cr | ₹-24 Cr | ₹25 Cr | ₹-73 Cr |
What is the latest Consolidated Net Profit of NECTAR LIFESCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹-114 Cr |
| Mar2025 | ₹5.00 Cr |
| Mar2024 | ₹-24 Cr |
| Mar2023 | ₹25 Cr |
| Mar2022 | ₹-73 Cr |
How is Consolidated Net Profit of NECTAR LIFESCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹-114 Cr | Negative | |
| Mar2025 | ₹5.00 Cr | Positive | |
| Mar2024 | ₹-24 Cr | Negative | |
| Mar2023 | ₹25 Cr | Positive | |
| Mar2022 | ₹-73 Cr | - | |
Compare Consolidated Net Profit of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹200.7 Cr | -4.1% | -14.6% | -30.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -4.1% |
-14.6% |
-30.1% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses